z-logo
open-access-imgOpen Access
Halting Coronavirus Replication
Author(s) -
Kira Smith
Publication year - 2020
Publication title -
epidemiology - open journal
Language(s) - English
Resource type - Journals
ISSN - 2473-4780
DOI - 10.17140/epoj-5-119
Subject(s) - coronavirus , sirtuin , viral replication , virology , replication (statistics) , biology , mechanism (biology) , covid-19 , virus , microbiology and biotechnology , genetics , disease , gene , medicine , infectious disease (medical specialty) , physics , pathology , quantum mechanics , acetylation
Sirtuin 1 (SIRT1) inhibitors can reduce replication of many viruses with certain characteristics similar to those of coronaviruses, while the p53 protein is another important factor in the down-regulation of viral growth. Tenovin is a class of small molecules that inhibit Sirtuin 1 and 2, in addition to activating the p53 protein, by means of regulating the interactions used by coronaviruses as a self-defense mechanism. By blocking virus growth and continuous replication, with already tested antiviral medicines, the promise of coronavirus disease 2019 (COVID-19) eradication exists.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom